חדש AASLD/IDSA Hepatitis C Virus Practice Recommendations: An Online Resource
Easel Recommendations on Treatment of Hepatitis C, 2014 - Short Version
Easel Recommendations on Treatment of Hepatitis C, 2014 - Long Version
Management of chronic hepatitis B in childhood: ESPGHAN
clinical practice guidelines Consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition: Etienne M. Sokal1, Massimiliano Paganelli,, Stefan Wirth, Piotr Socha, Pietro Vajro, Florence Lacaille, Deirdre Kelly, Giorgina Mieli-Vergani, Journal of Hepatology 2013 vol. 59 j 814–829
TIPS: 25 years later: Martin Rössle, Journal of Hepatology 2013 vol. 59 j 1081–1093
Update on primary sclerosing cholangitis: Tom H. Karlsen1,2, Kirsten Muri Boberg Journal of Hepatology 2013 vol. 59 j 571–582
Management of anemia induced by triple therapy in patients
with chronic hepatitis C: Challenges, opportunities
and recommendations: Manuel Romero-Gómez1, Marina Berenguer, Esther Molina, José Luis Cal, Journal of Hepatology 2013 vol. 59 j 1323–1330
Acute kidney injury (AKI) in cirrhosis: Should we changecurrent definition and diagnostic criteria of renal failure in cirrhosis? Vicente Arroyo, Journal of Hepatology 2013 vol. 59 j 415–417
D-livering the message: The importance of vitamin D status in chronic liver disease: Matthew T. Kitson et al.,Journal of Hepatology 2012 vol. 57 j 897–909
S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility: Quentin M. Anstee et al.,Journal of Hepatology 2012 vol. 57 j 1097–1109
Hepatorenal syndrome, MELD score and liver transplantation - An evolving issue with relevant implications for clinical practice: Paolo Angeli et al., Journal of Hepatology 2012 vol. 57 j 1135–1140
Assessment of risk for non-hepatic surgery in cirrhotic patients: Prashant Bhangui et al., Journal of Hepatology 2012 vol. 57 j 874–884
The option of HBIG-free prophylaxis against recurrent HBV: Alyson N. Fox et al., Journal of Hepatology 2012 vol. 56 j 1189–1197
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection: European Association for the Study of the Liver, Journal of Hepatology 2012 vol. 57 j 167–185
Review and Management of Drug Interactions With Boceprevir and Telaprevir: Jennifer J. Kiser et al.,HEPATOLOGY, Vol. 55, No. 5, 2012
Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review: George V. Papatheodoridis et al., Journal of Hepatology 2012 vol. 57 j 196–202
Adrenocortical Dysfunction in Liver Disease: A Systematic Review: Giuseppe Fede et al., HEPATOLOGY, Vol. 55, No. 4, 2012
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma: Josep M. Llovet (EASL); Michel Ducreux (EORTC) et al., Journal of Hepatology 2012 vol. 56 j 908–943
Boceprevir: Haripriya Maddur et al., Hepatology Volume 54, Issue 6, pages 2254–2258, December 2011
Hepatitis E: Rakesh Aggarwal et al., Hepatology Volume 54, Issue 6, pages 2218–2226, December 2011
Intensive care of the patient with cirrhosis: Jody C. Olson et al., Hepatology Volume 54, Issue 5, pages 1864–1872, November 2011
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases:
Ghany et al., Hepatology, October 2011
Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
The Coagulopathy of Chronic Liver Disea
Idiopathic noncirrhotic portal hypertension
Terlipressin: an asset for hepatologists!
A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
revised classification renal dysf in cirrhosis
Risk of chronic kidney disease in patients with non-alcoholic
Management of hepatitis C virus genotype 4
טריגליצרידים ומחלות קרדיווסקולאריות נייר עמדה של ארגון הלב האמריקאי
נייר עמדה בנושא סרטן הכבד של החברה האמריקאית לחקר הכבד
Hepatology Volume 53, 2011
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix,1 and Morris Sherman2
Hepatology Volume 53, Issue 3, pages 1020–1022, March 2011
Clifford J. Rosen, M.D.
N Engl J Med 2011; 364:248-254 January 20, 2011
Noninvasive assessment of liver fibrosis
Stella M. Martínez, Gonzalo Crespo, Miquel Navasa, Xavier Forns
Hepatology Volume 53, Issue 1, pages 325–335, January 2011
Positron emission tomography scan for a hepatic mass
Boris Blechacz, Gregory J. Gores
Hepatology Volume 52, Issue 6, pages 2186–2191, December 2010
Hepatitis C pharmacogenetics: State of the art in 2010
Nezam H. Afdhal et al; Hepatology Volume 53, Issue 1, pages 336–345, January 2011
Overlap syndromes: The International Autoimmune Hepatitis
Group (IAIHG) position statement on a controversial issue Kirsten Muri Boberg, Roger W. Chapman, Gideon M. Hirschfield, Ansgar W. Lohse, Michael P. Manns, Erik Schrumpf, on behalf of the International Autoimmune Hepatitis Group, Journal of Hepatology 2011 vol. 54 j 374–385
Jasmohan S. Bajaj, Oliviero Riggio, Hepatology Volume 52, Issue 4, pages 1484–1488, October 2010
Hepcidin in human iron disorders: Therapeutic implications
Antonello Pietrangelo, Journal of Hepatology 2011 vol. 54 j 173–181
Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives
Elsa Solà, Pere Ginès, Journal of Hepatology December 2010 (Vol. 53, Issue 6, Pages 1135-1145)
Revising consensus in portal hypertension: Report of the Baveno V
consensus workshop on methodology of diagnosis and therapy, in portal hypertension Roberto de Franchis, On behalf of the Baveno V Faculty, Journal of Hepatology 2010 vol. 53 j 762–768
position statement on NAFLD/NASH based on the EASL 2009 special conference
Vlad Ratziua et al., Journal of Hepatology 2010 vol. 53 j 372–384
Medical and surgical treatment options for polycystic liver disease
Joost P.H. Drenth et al., Hepatology Volume 52, Issue 6, pages 2223–2230, December 2010
Loco-regional treatment of hepatocellular carcinoma
Riccardo Lencioni, Hepatology Volume 52, Issue 2, pages 762–773, August 2010
Hemostasis and thrombosis in patients with liver disease: The ups and downs
Ton Lisman et al., Journal of Hepatology 2010 vol. 53 j 362–371 (August 2010)
Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials
Mieke M.H. Lamers, Martijn G.H. van Oijen, Martine Pronk, Joost P.H. Drenth , Journal of Hepatology July 2010 (Vol. 53, Issue 1, Pages 191-198)
Søren Møller, Jens H. Henriksen, Journal of Hepatology July 2010 (Vol. 53, Issue 1, Pages 179-190)
EASL clinical practice guidelines for HFE hemochromatosis
European Association for the Study of the Liver, Journal of Hepatology 2010 vol. 53 j 3–22
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix and Morris Sherman; HEPATOLOGY, July 2010
Fitness Versus Fatness: Moving Beyond Weight Loss in Nonalcoholic Fatty Liver Disease
Nathan A. Johnson and Jacob George, Hepatology Volume 52, Issue 1, pages 370–380, July 2010
Diagnosis and management of autoimmune hepatitis
Manns et al., Hepatology Volume 51, Issue 6, pages 2193–2213, June 2010
HEPATOLOGY, Vol. 51, No. 3, 2010
Primary biliary cirrhosis: A 2010 update
Raoul Poupon, Volume 52, Issue 5, Pages 745-758 (May 2010)
Hepatobiliary Complications of Hematopoietic Cell Transplantation,
40 Years On, George B. McDonald M.D, Hepatology Volume 51, Issue 4, pages 1450–1460, April 2010
Guadalupe Garcia-Tsao et al., Hepatology Volume 51, Issue 4, pages 1445–1449, April 2010
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman et al.; Hepatology Volume 51, Issue 2, pages 660–678, February 2010
Thomas D. Boyer and Ziv J. Haskal, HEPATOLOGY, January 2010
Robert S. O’Shea, Srinivasan Dasarathy, Arthur J. McCullough; HEPATOLOGY, January 2010
GASTROENTEROLOGY 2010;138:108–115
Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon
Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection GASTROENTEROLOGY 2010;138:116–122
Re-treating Patients With Chronic Hepatitis C Who Have Not Responded to Peginterferon-α2b
Ann Intern Med. 2009;150:528-540
Thierry Gustot, Hepatology Volume 50, Issue 6, pages 2022–2033, December 2009
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
European Association for the Study of the Liver, Journal of Hepatology 51 (2009) 237–267
Chronic Hepatitis B: Update 2009
LOK AND MCMAHON, HEPATOLOGY, September 2009
Keith D. Lindor et al, HEPATOLOGY, July 2009
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Ghany et al., HEPATOLOGY, April 2009
AASLD POSITION PAPER | Liver Biopsy
Don C. et al., HEPATOLOGY, March 2009
Diagnosis and Treatment of Wilson Disease: An Update
Eve A. Roberts and Michael L. Schilsky, HEPATOLOGY, June 2008
